These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 10223941)

  • 1. Pharmacokinetics of rifapentine in subjects seropositive for the human immunodeficiency virus: a phase I study.
    Keung AC; Owens RC; Eller MG; Weir SJ; Nicolau DP; Nightingale CH
    Antimicrob Agents Chemother; 1999 May; 43(5):1230-3. PubMed ID: 10223941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel dosing strategies increase exposures of the potent antituberculosis drug rifapentine but are poorly tolerated in healthy volunteers.
    Dooley KE; Savic RM; Park JG; Cramer Y; Hafner R; Hogg E; Janik J; Marzinke MA; Patterson K; Benson CA; Hovind L; Dorman SE; Haas DW;
    Antimicrob Agents Chemother; 2015; 59(6):3399-405. PubMed ID: 25824215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-dose pharmacokinetics of rifapentine in elderly men.
    Keung AC; Eller MG; Weir SJ
    Pharm Res; 1998 Aug; 15(8):1286-91. PubMed ID: 9706063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single and multiple dose pharmacokinetics of rifapentine in man: part II.
    Keung A; Eller MG; McKenzie KA; Weir SJ
    Int J Tuberc Lung Dis; 1999 May; 3(5):437-44. PubMed ID: 10331734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acquired rifamycin monoresistance in patients with HIV-related tuberculosis treated with once-weekly rifapentine and isoniazid. Tuberculosis Trials Consortium.
    Vernon A; Burman W; Benator D; Khan A; Bozeman L
    Lancet; 1999 May; 353(9167):1843-7. PubMed ID: 10359410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzyme induction observed in healthy volunteers after repeated administration of rifapentine and its lack of effect on steady-state rifapentine pharmacokinetics: part I.
    Keung A; Reith K; Eller MG; McKenzie KA; Cheng L; Weir SJ
    Int J Tuberc Lung Dis; 1999 May; 3(5):426-36. PubMed ID: 10331733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of four different meal types on the population pharmacokinetics of single-dose rifapentine in healthy male volunteers.
    Zvada SP; Van Der Walt JS; Smith PJ; Fourie PB; Roscigno G; Mitchison D; Simonsson US; McIlleron HM
    Antimicrob Agents Chemother; 2010 Aug; 54(8):3390-4. PubMed ID: 20516273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic interaction of rifapentine and raltegravir in healthy volunteers.
    Weiner M; Egelund EF; Engle M; Kiser M; Prihoda TJ; Gelfond JA; Mac Kenzie W; Peloquin CA
    J Antimicrob Chemother; 2014 Apr; 69(4):1079-85. PubMed ID: 24343893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Once-weekly rifapentine and isoniazid for tuberculosis prevention in patients with HIV taking dolutegravir-based antiretroviral therapy: a phase 1/2 trial.
    Dooley KE; Savic R; Gupte A; Marzinke MA; Zhang N; Edward VA; Wolf L; Sebe M; Likoti M; Fyvie MJ; Shibambo I; Beattie T; Chaisson RE; Churchyard GJ;
    Lancet HIV; 2020 Jun; 7(6):e401-e409. PubMed ID: 32240629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of rifapentine in patients with varying degrees of hepatic dysfunction.
    Keung AC; Eller MG; Weir SJ
    J Clin Pharmacol; 1998 Jun; 38(6):517-24. PubMed ID: 9650541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repeated administration of high-dose intermittent rifapentine reduces rifapentine and moxifloxacin plasma concentrations.
    Dooley K; Flexner C; Hackman J; Peloquin CA; Nuermberger E; Chaisson RE; Dorman SE
    Antimicrob Agents Chemother; 2008 Nov; 52(11):4037-42. PubMed ID: 18765687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Twice-Daily Dolutegravir-Based Antiretroviral Therapy With 1 Month of Daily Rifapentine and Isoniazid for Tuberculosis Prevention.
    Podany AT; Cramer Y; Imperial M; Rosenkranz SL; Avihingsanon A; Arduino R; Samaneka W; Gelmanova I; Savic R; Swindells S; Dawson R; Luetkemeyer AF
    Clin Infect Dis; 2024 Oct; 79(4):983-989. PubMed ID: 38568956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of rifapentine at 600, 900, and 1,200 mg during once-weekly tuberculosis therapy.
    Weiner M; Bock N; Peloquin CA; Burman WJ; Khan A; Vernon A; Zhao Z; Weis S; Sterling TR; Hayden K; Goldberg S;
    Am J Respir Crit Care Med; 2004 Jun; 169(11):1191-7. PubMed ID: 14962821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New regimens to prevent tuberculosis in adults with HIV infection.
    Martinson NA; Barnes GL; Moulton LH; Msandiwa R; Hausler H; Ram M; McIntyre JA; Gray GE; Chaisson RE
    N Engl J Med; 2011 Jul; 365(1):11-20. PubMed ID: 21732833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. One Month of Rifapentine plus Isoniazid to Prevent HIV-Related Tuberculosis.
    Swindells S; Ramchandani R; Gupta A; Benson CA; Leon-Cruz J; Mwelase N; Jean Juste MA; Lama JR; Valencia J; Omoz-Oarhe A; Supparatpinyo K; Masheto G; Mohapi L; da Silva Escada RO; Mawlana S; Banda P; Severe P; Hakim J; Kanyama C; Langat D; Moran L; Andersen J; Fletcher CV; Nuermberger E; Chaisson RE;
    N Engl J Med; 2019 Mar; 380(11):1001-1011. PubMed ID: 30865794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of rifapentine in children.
    Blake MJ; Abdel-Rahman SM; Jacobs RF; Lowery NK; Sterling TR; Kearns GL
    Pediatr Infect Dis J; 2006 May; 25(5):405-9. PubMed ID: 16645503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Population Pharmacokinetic Analysis Shows that Arylacetamide Deacetylase (AADAC) Gene Polymorphism and HIV Infection Affect the Exposure of Rifapentine.
    Francis J; Zvada SP; Denti P; Hatherill M; Charalambous S; Mungofa S; Dawson R; Dorman S; Gupte N; Wiesner L; Jindani A; Harrison TS; Olagunju A; Egan D; Owen A; McIlleron HM
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30670438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potent twice-weekly rifapentine-containing regimens in murine tuberculosis.
    Rosenthal IM; Williams K; Tyagi S; Peloquin CA; Vernon AA; Bishai WR; Grosset JH; Nuermberger EL
    Am J Respir Crit Care Med; 2006 Jul; 174(1):94-101. PubMed ID: 16574936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-dose pharmacokinetics of rifapentine in women.
    Keung AC; Eller MG; Weir SJ
    J Pharmacokinet Biopharm; 1998 Feb; 26(1):75-85. PubMed ID: 9773393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rifapentine pharmacokinetics in adolescents.
    Marshall JD; Abdel-Rahman S; Johnson K; Kauffman RE; Kearns GL
    Pediatr Infect Dis J; 1999 Oct; 18(10):882-8. PubMed ID: 10530584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.